These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 2160590)

  • 1. Characterization of pp85, a target of oncogenes and growth factor receptors.
    Cohen B; Liu YX; Druker B; Roberts TM; Schaffhausen BS
    Mol Cell Biol; 1990 Jun; 10(6):2909-15. PubMed ID: 2160590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tyrosine phosphorylation is a signal for the trafficking of pp85, an 85-kDa phosphorylated polypeptide associated with phosphatidylinositol kinase activity.
    Cohen B; Yoakim M; Piwnica-Worms H; Roberts TM; Schaffhausen BS
    Proc Natl Acad Sci U S A; 1990 Jun; 87(12):4458-62. PubMed ID: 1693771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions of polyomavirus middle T with the SH2 domains of the pp85 subunit of phosphatidylinositol-3-kinase.
    Yoakim M; Hou W; Liu Y; Carpenter CL; Kapeller R; Schaffhausen BS
    J Virol; 1992 Sep; 66(9):5485-91. PubMed ID: 1380095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of polyoma virus middle T antigen and pp60src with cytoskeletal elements.
    Ballmer-Hofer K; Ziegler A; Burger MM
    Oncogene; 1988 Oct; 3(4):365-71. PubMed ID: 2856248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Common elements in growth factor stimulation and oncogenic transformation: 85 kd phosphoprotein and phosphatidylinositol kinase activity.
    Kaplan DR; Whitman M; Schaffhausen B; Pallas DC; White M; Cantley L; Roberts TM
    Cell; 1987 Sep; 50(7):1021-9. PubMed ID: 2441878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet-derived growth factor induces phosphatidylinositol 3-kinase release from the middle T-pp60c-src complex and association with the platelet-derived growth factor receptor.
    Zhang QX; Baldwin GS
    Growth Factors; 1994; 10(1):41-51. PubMed ID: 7514012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inositol trisphosphate levels in cells expressing wild-type and mutant polyomavirus middle T antigens: evidence for activation of phospholipase C via activation of pp60c-src.
    Gorga FR; Riney CE; Benjamin TL
    J Virol; 1990 Jan; 64(1):105-12. PubMed ID: 2152807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Most of the substrates of oncogenic viral tyrosine protein kinases can be phosphorylated by cellular tyrosine protein kinases in normal cells.
    Kamps MP; Sefton BM
    Oncogene Res; 1988 Sep; 3(2):105-15. PubMed ID: 2465525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional role of GTPase-activating protein in cell transformation by pp60v-src.
    DeClue JE; Vass WC; Johnson MR; Stacey DW; Lowy DR
    Mol Cell Biol; 1993 Nov; 13(11):6799-809. PubMed ID: 7692232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An 81 kd protein complexed with middle T antigen and pp60c-src: a possible phosphatidylinositol kinase.
    Courtneidge SA; Heber A
    Cell; 1987 Sep; 50(7):1031-7. PubMed ID: 2441879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous overexpression of avian pp60c-src and polyomavirus middle T antigen in mammalian cells.
    Cook DN; Pavloff N; Hassell JA
    J Virol; 1990 May; 64(5):2392-5. PubMed ID: 2157894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphorylation of middle T by pp60c-src: a switch for binding of phosphatidylinositol 3-kinase and optimal tumorigenesis.
    Talmage DA; Freund R; Young AT; Dahl J; Dawe CJ; Benjamin TL
    Cell; 1989 Oct; 59(1):55-65. PubMed ID: 2551507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence that a phosphotyrosine-containing 120,000 Da protein from Rous sarcoma virus-infected cells is phosphorylated by pp60v-src.
    Lau AF
    Oncogene Res; 1989; 4(3):185-94. PubMed ID: 2472591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polyoma virus middle T antigen-pp60c-src complex associates with purified phosphatidylinositol 3-kinase in vitro.
    Auger KR; Carpenter CL; Shoelson SE; Piwnica-Worms H; Cantley LC
    J Biol Chem; 1992 Mar; 267(8):5408-15. PubMed ID: 1372000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of tumor formation and cell transformation by polyoma middle T antigen in the absence of Src.
    Thomas JE; Aguzzi A; Soriano P; Wagner EF; Brugge JS
    Oncogene; 1993 Sep; 8(9):2521-9. PubMed ID: 7689725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tyr527 is phosphorylated in pp60c-src: implications for regulation.
    Cooper JA; Gould KL; Cartwright CA; Hunter T
    Science; 1986 Mar; 231(4744):1431-4. PubMed ID: 2420005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Restriction of the in vitro and in vivo tyrosine protein kinase activities of pp60c-src relative to pp60v-src.
    Coussens PM; Cooper JA; Hunter T; Shalloway D
    Mol Cell Biol; 1985 Oct; 5(10):2753-63. PubMed ID: 2426575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of phosphatidylinositol kinase activity with polyoma middle-T competent for transformation.
    Whitman M; Kaplan DR; Schaffhausen B; Cantley L; Roberts TM
    Nature; 1985 May 16-22; 315(6016):239-42. PubMed ID: 2987699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transformation by polyoma virus middle T antigen.
    Courtneidge SA
    Cancer Surv; 1986; 5(2):173-82. PubMed ID: 2430702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A mutation in v-src that removes a single conserved residue in the SH-2 domain of pp60v-src restricts transformation in a host-dependent manner.
    Verderame MF; Kaplan JM; Varmus HE
    J Virol; 1989 Jan; 63(1):338-48. PubMed ID: 2462061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.